Aradigm Initiates Phase 2 Study Of Inhaled Liposomal Ciprofloxacin In Bronchiectasis

New cases in Pous 2064, HIV = 175, AIDS = 26, Death = 2. HIV rate is very high in Housewives than sex workers in Nepal ! ! ! HIV status in Nepal till 2005: Total Adult=70000, Adult Prevalence (15-49)=0.55%, Number of Women (15-49) LWHA=15,310 (22%), HIV Prevalence rate in IDUs=32.7%, HIV prevalence rate in sex worker=3.8%, HIV prevalence rate in client of SW=2.1%. The latest U.N. report shows that 65 million people have been infected with HIV since it was first identified 25 years ago. Twenty five million people have died of AIDS.

Welcome to the xenoMED, an online Medical Community where Academically sound, Professionally conscious and Socially responsible Medical Students, Doctors & Health Professionals interact with each other globally.

Medicine is the only profession that incessantly tries to destroy its own existence. Howsoever you may be associated with basic and/or clinical medicine - student or professor, physician or surgeon, undergraduate or postgraduate - this is your place to share your knowledge, and learn more. Just get the message across!

You are currently viewing our communiy as a guest which gives you limited access to view most discussions and access our other features. By joining our free community you will have access to post topics, communicate privately with other members (PM), respond to polls, upload content and access many other special features. Registration is fast, simple and absolutely free so please, Join Our Medical Cummunity Today!

If you have any problems with the registration process or your account login, please contact us.

		xenoMED > News Room > Health News > Medical News Today
Aradigm Initiates Phase 2 Study Of Inhaled Liposomal Ciprofloxacin In Bronchiectasis

LinkBack

Thread Tools

Display Modes

(#1 (permalink))

News is Offline

Senior Member

Posts: 648

Thanks: 0

Thanked 29 Times in 29 Posts

Join Date: Sep 2007

Aradigm Initiates Phase 2 Study Of Inhaled Liposomal Ciprofloxacin In Bronchiectasis - 21-06-2008, 06:10 AM

Aradigm Corporation (OTCBB: ARDM) announced it has initiated a multicenter Phase 2 clinical trial of its inhaled liposomal ciprofloxacin in adult patients with non-cystic fibrosis bronchiectasis. Following an antibiotic washout period, 36 patients will be enrolled to receive daily inhaled liposomal ciprofloxacin for a period of 28 consecutive days.

More...

Remove advertisements

Sponsored links

« Sepracor Announces Phase III Data For Eslicarbazepine Acetate Presented At Ninth Eila | Oncolin Therapeutics Announces Its Cancer Technology Will Be Presented At The 20th EO »

Thread Tools
Show Printable Version Email this Page
Display Modes
Linear Mode Switch to Hybrid Mode Switch to Threaded Mode

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts vB code is On Smilies are On [IMG] code is On HTML code is Off Trackbacks are On Pingbacks are On Refbacks are On

Similar Threads
Thread	Thread Starter	Forum	Replies	Last Post
ViroPharma Initiates Phase 3 Study Of CAMVIA(TM) (maribavir) In Liver Transplant Pati	Angel	Medical News Today	0	06-07-2007 12:41 AM
PARI Pharma Presents Study Results Of Sinus Delivery And Inhaled Liposomal Ciclospori	Angel	Medical News Today	0	15-06-2007 12:32 AM
BioMarin Initiates Phase 2a Clinical Study Of 6R-BH4 In Sickle Cell Disease	Angel	Medical News Today	0	03-05-2007 12:12 AM
Baxter Presents Phase I Inhaled Insulin Study Results At Respiratory Drug Delivery Co	Angel	Medical News Today	0	21-04-2007 12:30 AM
BioMarin Initiates Phase 2 Clinical Study Of 6R-BH4 In Peripheral Arterial Disease	Angel	Medical News Today	0	08-01-2007 12:10 AM

Remove advertisements

Hosted and Maintained by: